RS50416B - Prečišćeni lh - Google Patents

Prečišćeni lh

Info

Publication number
RS50416B
RS50416B YUP-603/02A YUP60302A RS50416B RS 50416 B RS50416 B RS 50416B YU P60302 A YUP60302 A YU P60302A RS 50416 B RS50416 B RS 50416B
Authority
RS
Serbia
Prior art keywords
column
elution
phase hplc
process according
exchange chromatography
Prior art date
Application number
YUP-603/02A
Other languages
English (en)
Serbian (sr)
Inventor
Gianfranco PARADISI
Mara Rossi
Laura SCAGLIA
Original Assignee
Laboratoires Serono Sa.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono Sa., filed Critical Laboratoires Serono Sa.,
Publication of YU60302A publication Critical patent/YU60302A/sh
Publication of RS50416B publication Critical patent/RS50416B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Semiconductor Lasers (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
YUP-603/02A 2000-02-22 2001-01-22 Prečišćeni lh RS50416B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00103692 2000-02-22

Publications (2)

Publication Number Publication Date
YU60302A YU60302A (sh) 2005-09-19
RS50416B true RS50416B (sr) 2009-12-31

Family

ID=8167926

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-603/02A RS50416B (sr) 2000-02-22 2001-01-22 Prečišćeni lh

Country Status (30)

Country Link
US (2) US7053054B2 (enExample)
EP (2) EP1777231A3 (enExample)
JP (1) JP4959898B2 (enExample)
KR (1) KR100808149B1 (enExample)
CN (1) CN100480258C (enExample)
AT (1) ATE356138T1 (enExample)
AU (1) AU780377B2 (enExample)
BG (1) BG65761B1 (enExample)
BR (2) BR122012018280B8 (enExample)
CA (1) CA2399100C (enExample)
CY (1) CY1108056T1 (enExample)
CZ (1) CZ303274B6 (enExample)
DE (1) DE60127100T2 (enExample)
DK (1) DK1261622T3 (enExample)
EA (1) EA004385B1 (enExample)
EE (1) EE04932B1 (enExample)
ES (1) ES2278722T3 (enExample)
HR (1) HRP20020651B1 (enExample)
HU (1) HU227007B1 (enExample)
IL (2) IL151309A0 (enExample)
MX (1) MXPA02007867A (enExample)
NO (1) NO328693B1 (enExample)
PL (1) PL207728B1 (enExample)
PT (1) PT1261622E (enExample)
RS (1) RS50416B (enExample)
SI (1) SI1261622T1 (enExample)
SK (1) SK287041B6 (enExample)
UA (2) UA78676C2 (enExample)
WO (1) WO2001062774A2 (enExample)
ZA (1) ZA200206108B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1777231A3 (en) * 2000-02-22 2007-11-07 Laboratoires Serono SA Process of purication of LH and recombinant hLH purified by that method
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE602004030546D1 (de) * 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
EA008924B1 (ru) * 2003-12-22 2007-08-31 Арес Трейдинг С.А. Способ очистки фсг
ES2344657T3 (es) * 2004-10-04 2010-09-02 Novetide, Ltd. Procedimiento de intercambio de contraion para peptidos.
EP1809663B1 (en) * 2004-11-09 2008-09-17 Ares Trading S.A. Method for purifying fsh
EP1917276B1 (en) 2005-08-26 2018-03-21 Ares Trading S.A. Process for the preparation of glycosylated interferon beta
AU2006323925B2 (en) * 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
JP2011500757A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Ｆｃ含有タンパク質の精製方法
JP2011500756A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Ｆｃ融合タンパク質を精製する方法
CN101928342B (zh) * 2009-06-18 2013-05-08 上海天伟生物制药有限公司 一种高纯度绝经期促性腺素及其制备方法和用途
US10400019B2 (en) * 2014-05-01 2019-09-03 Virginia Tech Intellectual Properties, Inc. Keratin nanomaterials and methods of production
CN104569441B (zh) * 2015-01-19 2016-02-03 成都大熊猫繁育研究基地 大熊猫尿液促黄体素的酶联检测方法及其应用
BR112021022860A2 (pt) 2019-05-16 2022-01-18 Ceva Sante Animale Composições e métodos para aumentar o desempenho da reprodução em mamíferos não humanos com uso de hormônio luteinizante recombinante

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002757A1 (en) * 1988-09-02 1990-03-22 Integrated Genetics, Inc. Heteropolymeric protein
ATE148171T1 (de) * 1989-02-21 1997-02-15 Univ Washington Modifizierte formen von fortpflanzungshormonen
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
CN100404551C (zh) * 1997-06-25 2008-07-23 雪兰诺实验室有限公司 二硫键交联的糖蛋白激素类似物及其制备和应用
EP1777231A3 (en) * 2000-02-22 2007-11-07 Laboratoires Serono SA Process of purication of LH and recombinant hLH purified by that method

Also Published As

Publication number Publication date
AU3543601A (en) 2001-09-03
HRP20020651B1 (en) 2011-01-31
HUP0301814A2 (hu) 2003-08-28
ZA200206108B (en) 2003-07-31
UA92145C2 (en) 2010-10-11
CN100480258C (zh) 2009-04-22
PL362891A1 (en) 2004-11-02
BG107001A (bg) 2003-04-30
PT1261622E (pt) 2007-04-30
DE60127100D1 (de) 2007-04-19
EA004385B1 (ru) 2004-04-29
HU227007B1 (en) 2010-04-28
SK287041B6 (sk) 2009-10-07
CN1404486A (zh) 2003-03-19
EP1261622A2 (en) 2002-12-04
JP2003532636A (ja) 2003-11-05
IL151309A (en) 2010-11-30
CA2399100A1 (en) 2001-08-30
DE60127100T2 (de) 2007-06-28
ATE356138T1 (de) 2007-03-15
EE200200464A (et) 2003-12-15
PL207728B1 (pl) 2011-01-31
SI1261622T1 (sl) 2007-06-30
US20060079460A1 (en) 2006-04-13
WO2001062774A2 (en) 2001-08-30
NO328693B1 (no) 2010-04-26
KR100808149B1 (ko) 2008-02-29
MXPA02007867A (es) 2003-02-10
DK1261622T3 (da) 2007-05-29
BG65761B1 (bg) 2009-10-30
BRPI0108553B1 (pt) 2016-06-14
YU60302A (sh) 2005-09-19
BR122012018280B1 (pt) 2018-01-09
HRP20020651A2 (en) 2004-12-31
BRPI0108553B8 (pt) 2021-05-25
AU780377B2 (en) 2005-03-17
JP4959898B2 (ja) 2012-06-27
EP1777231A2 (en) 2007-04-25
EP1261622B1 (en) 2007-03-07
CA2399100C (en) 2011-11-08
UA78676C2 (en) 2007-04-25
EE04932B1 (et) 2007-12-17
CZ20022856A3 (cs) 2003-01-15
NO20023963D0 (no) 2002-08-20
EA200200893A1 (ru) 2003-02-27
BR122012018280B8 (pt) 2021-05-25
CZ303274B6 (cs) 2012-07-11
CY1108056T1 (el) 2013-09-04
IL151309A0 (en) 2003-04-10
HK1052014A1 (zh) 2003-08-29
ES2278722T3 (es) 2007-08-16
US20030186893A1 (en) 2003-10-02
BR0108553A (pt) 2003-12-23
EP1777231A3 (en) 2007-11-07
HUP0301814A3 (en) 2004-10-28
KR20030001358A (ko) 2003-01-06
US7053054B2 (en) 2006-05-30
SK12052002A3 (sk) 2002-12-03
WO2001062774A3 (en) 2002-03-14
NO20023963L (no) 2002-08-20

Similar Documents

Publication Publication Date Title
RS60302B1 (sr) Inhibitori bromodomena
RS60202B1 (sr) Jedinjenja cikličnog etra pirazol-4-il-heterociklil-karboksamida i postupci primene
RS50416B (sr) Prečišćeni lh
CN100482679C (zh) 人绒毛膜促性腺激素的纯化方法
HK1052014B (en) Purified lh
HK1052016B (en) Process of purification of hcg